Results 221 to 230 of about 129,195 (289)

Protein glycosylation in lung cancer from a mass spectrometry perspective

open access: yesMass Spectrometry Reviews, Volume 45, Issue 3, Page 455-475, May/June 2026.
ABSTRACT Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi   +2 more
wiley   +1 more source

Pleuritis Induced by Brigatinib During the Treatment of Non‐Small Cell Lung Cancer

open access: yesRespirology Case Reports, Volume 14, Issue 5, May 2026.
This is the first reported case of brigatinib‐induced pleuritis in ALK‐positive lung cancer. Pleural effusion resolved after discontinuation and did not recur at a reduced dose of 30 mg/day. Dose reduction to 30 mg/day could be a safe and effective management strategy in selected patients.
Shohei Yano   +7 more
wiley   +1 more source

Primary Hepatoid Adenocarcinoma of the Lung With Signet Ring Cell Differentiation and Widespread Osseous Metastases: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 5, May 2026.
We present a case of hepatoid adenocarcinoma in the lung which was initially misdiagnosed as pneumonia and rapidly progressed to widespread metastatic disease. This case emphasises the diagnostic difficulty, radiological and histopathologic characteristics, and aggressive clinical behaviour of this rare tumour and underscores the need for early ...
Rami Khader   +7 more
wiley   +1 more source

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study. [PDF]

open access: yesCA Cancer J Clin
Duan JC   +25 more
europepmc   +1 more source

A Case of Anti‐AMY1‐Positive Lung Squamous Cell Carcinoma With Severe Hyperamylasemia Linked to Disease Progression

open access: yesRespirology Case Reports, Volume 14, Issue 5, May 2026.
We present a case of anti‐AMY1‐positive lung squamous cell carcinoma (LUSC) with severe hyperamylasemia. To our knowledge, no previous cases of LUSC have been reported with both histological evidence of amylase production and hyperamylasemia. This case provides new evidence that LUSC can produce amylase and cause hyperamylasemia. ABSTRACT A 74‐year‐old
Yusuke Nakamura   +10 more
wiley   +1 more source

Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumonias. [PDF]

open access: yesTransl Lung Cancer Res
Terashima Y   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy